ITRM Insider Trading
Insider Ownership Percentage: 9.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Iterum Therapeutics Insider Trading History Chart
This chart shows the insider buying and selling history at Iterum Therapeutics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Iterum Therapeutics Share Price & Price History
Current Price: $1.54
Price Change: +0.30 (1.20%)
As of 01/17/2025 05:00 PM ET
Iterum Therapeutics Insider Trading History
Iterum Therapeutics Institutional Trading History
Data available starting January 2016
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Read More on Iterum Therapeutics
Volume
537,230 shs
Average Volume
677,344 shs
Market Capitalization
$42.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.33
Who are the company insiders with the largest holdings of Iterum Therapeutics?